Board Meeting28 Oct 2026, 04:13 pm
Zim Laboratories Board Meeting on Nov 4 to Approve Unaudited Financial Results
AI Summary
Zim Laboratories Ltd has announced that its Board of Directors will convene on November 4, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for both standalone and consolidated operations for the quarter ending September 30, 2026. In line with SEBI regulations, the company has also closed its trading window from October 1, 2026, to November 6, 2026, to prevent insider trading.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To approve unaudited financial results for Q2 FY27.
- Results will be considered on standalone and consolidated basis.
- Trading window closed from October 1 to November 6, 2026.
Price Impact
More from ZIMLAB